X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Nallian launches the Global Pharma Tracker – Early Adopter Program

Content Team by Content Team
13th March 2019
in Manufacturing, News, Packaging & Logistic
Nallian launches the Global Pharma Tracker – Early Adopter Program

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Data sharing specialist Nallian announces it will be launching the Global Pharma Tracker – Early Adopter Program at the IATA World Cargo Symposium in Singapore. The Global Pharma Tracker is the world’s first data sharing platform for end-to-end tracking and monitoring of temperature-controlled pharma shipments. Providing unparalleled levels of transparency and visibility, it empowers pharma actors to efficiently detect, act upon and ultimately prevent costly temperature excursions – currently causing billions worth of product loss every year.

Redefining temperature-controlled pharma shipments

The global pharma air cargo supply chain involves many partners: shippers, carriers, ground handlers, forwarders, cold chain service providers and airport authorities. In this fragmented supply chain, detecting excursions and defining why and where they happened is today a complex, time-consuming and manual process.

The Global Pharma Tracker Platform integrates logistics, temperature and quality data from this fragmented supply chain into a single, real-time view. This gives all stakeholders access to an enhanced data stream, providing valuable insights into their cargo flows and end-to-end visibility across the network. It empowers them to efficiently and unequivocally answer questions such as ‘where did the excursion happen?’ and ‘what caused it?’. Historical performance analysis will ultimately allow them to adopt a pro-active approach that prevents excursions from happening in the future.

Early Adopter Program

Following a successful Proof of Concept and Pilot phase, in collaboration with Pharma.Aero and their user group, including leading pharma shippers, handlers, airport authorities, forwarders and carriers (such as Pfizer, Johnson & Johnson, MSD, Brussels Airlines, Singapore Airlines, Mumbai Airport, Brussels Airport, Changi Airport, DHL Global Forwarding), the Global Pharma Tracker Platform is now made available to pharmaceutical actors who are keen to gain full control of their pharma shipments and set the standard for global pharma visibility.

Says Jean Verheyen, CEO Nallian: ‘We are excited to bring the benefits of our open data sharing platform to the pharmaceutical industry. Proven to generate transparency and efficiency across local cargo communities, expanding these to a global network such as the pharma supply chain is a logical next step in our ambition to bring the benefits of digitization and collaboration to the air cargo industry. Users of the Global Pharma Tracker will leverage the benefits manfold: internally, within their local community, across validated pharma corridors and ultimately across the global network. With a cost of 35 billion USD caused by temperature excursions, we trust the Global Pharma Tracker represents a major opportunity for the industry.”

Previous Post

Aprecia and CMIC have established an agreement to bring 3DP pharmaceutical products to Japan

Next Post

Gerresheimer to build manufacturing facility for Duma and Triveni containers in China

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post
Gerresheimer to build manufacturing facility for Duma and Triveni containers in China

Gerresheimer to build manufacturing facility for Duma and Triveni containers in China

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In